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Abstract 
 
The present work reveals the entropic preference in the two-step binding process of small 
molecule DNA minor groove binders (MGBs), involving the formation of a dimer in free 
solution followed by the binding of that dimer to DNA, which contrasts with the sequential or 
simultaneous cooperative binding of two unbound MGB molecules with DNA that is implicitly 
assumed in the majority of reported DNA-MGB binding studies. The results are generalized for 
the n-mer binding case and the methodological outcomes are discussed. 
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Introduction 
 
Small molecule recognition of nucleic acids has been the subject of extensive research since the 
elucidation of the DNA double-helix structure in 1953 by Watson and Crick. It is currently 
recognized as a key mechanism responsible for medico-biological properties of some drugs, in 
particular, those exerting antitumor properties [1,2]. One of the main difficulties in drug-based 
chemotherapy is the toxicity associated with nucleic acid targeted drug intervention. These toxic 
side effects associated with DNA binding drugs, at least in part, are directly linked to their 
relatively weak DNA sequence targeting specificity. The essential strategy in DNA-targeted drug 
design has been to find or create drugs with high specificity and cooperativity of binding to 
particular DNA sequences [2,3]. One of the rare examples when this strategy has been known to 
succeed was in the discovery of the lexitropsin class of DNA minor groove binders (to be 
referred to here as MGB ligands). These exert a characteristic homo-dimeric type of 
complexation by which two drug molecules simultaneously occupy a particular binding site 
[4,5]. The discovery of this DNA recognition mode opened up an important page in the history 
of DNA-targeted drug design and to date remains an active field of research (e.g. see [6] for 
review). 
 
So far the strategy and the methods used for investigating homo-dimeric binding have been 
completely focused on structural and/or thermodynamic investigations of 2:1 drug-DNA 
complexes in the crystalline or solution phases whilst ignoring the possible route by which 
homo-dimer formation occurs. However, a recent question was raised concerning whether the 
formation of drug homo-dimer occurs at the heart of the DNA binding site through sequential or 
simultaneous binding of ligands (i.e. via a DNA-dependent process), or whether it occurs in free 
solution due to drug dimerization as a prelude to DNA complexation during a pre-assembly stage 
(i.e. via a DNA-independent process) (Fig. 1) [7]. If the DNA-independent process is operating, 
the method of investigation concerning homo-dimeric binding should be complemented by 
investigation of ligand self-assembly in the absence of DNA as a pre-requisite to further ligand-
DNA binding studies. This is an important methodological consequence not so far considered in 
this field of research. In the present work we provide the statistical-thermodynamic rationale for 
addressing this question. 
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Figure 1. Schematic representation of DNA-dependent (a) and DNA-independent (b) routes of 
the MGB ligands binding with DNA. For (a) Ligand 1 and Ligand 2 may also bind at the same 
time but this does not involve association between the ligands prior to DNA binding. 
 
 
Results and Discussion 
 
Evidence supportive of binding mode preference for homo-dimeric binding with DNA. 
Data available in the literature on the dimerization of MGB ligands are quite scarce and limited 
to the self-association of some typical DNA binders (e.g. [7-10]). Nevertheless some preliminary 
conclusions may be drawn, which indirectly support some preference for a DNA-independent 
mechanism of homo-dimeric binding to DNA: 
 
(i) MGB ligands that exert homo-dimeric binding typically also exert quite strong self-
association in solution in the absence of DNA (e.g. [7-10]); 
(ii) the structure of known MGB dimers in free solution appears to be very similar to that 
found in ligand/DNA complexes for 2:1 binding. In particular, the anti-parallel 
orientation and maintenance of stacking between aromatic moieties of the molecules 
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comprising MGB dimers and the dimers bound to DNA seem to be preserved (e.g. 
[7,10]); 
(iii) the homo-dimeric 2:1 binding of MGB ligands with DNA typically features high 
cooperativity with very minor contributions from the intermediate 1:1 stage [11,12], 
suggesting that the binding process is not sequential. 
 
Under the assumption that the conclusions listed above are valid for the homo-dimeric binding 
discussed in this paper, it follows that homo-dimeric binding occurs through either of two 
mechanisms. This can be on DNA through simultaneous binding of two MGB ligands with DNA 
(i.e. a DNA-dependent process in which DNA acts as the former or template onto which the 
ligands assemble), or it can go via a two-step process whereby dimerization in free solution is 
then followed by the preformed dimer binding with the DNA (i.e. a DNA-independent process). 
To the best of our knowledge no experimental or theoretical evidence has been put forward to 
date which enables these two binding routes to be distinguished from one another. Valuable 
information on binding route can be gained from kinetic studies, e.g. those pioneered by 
D.Crothers with respect to homo-dimeric binding of distamycin passing through sequential 
(DNA-dependent) 1:1 to 2:1 route [13,14]. However, in the case of the minor contribution from 
1:1 binding discussed in the present work, it would be very difficult, if not impossible, to 
distinguish in kinetic terms dimer formation in free solution followed by binding with DNA from 
dimer formation at the DNA followed by dimer adaptation to DNA. 
 
In summary, no apparent structural or energetic preference for one or other route can be 
postulated a priori. In the context of this work it is assumed that these two routes are 
enthalpically indistinguishable. If so, it is reasonable to further explore the entropic change 
associated with the DNA-dependent and DNA-independent homo-dimeric binding processes. 
 
Entropic cost of selecting a particular route of binding. 
Let us generalize the task and consider the case of an aggregate binding with DNA and 
containing n molecules (the n-mer binding model), for which the homo-dimeric binding (n=2) 
constitutes a partial case. The ligand self-association required to form n-mers is commonly 
described within the framework of an isodesmic aggregation model, which assumes that the self-
association occurs by sequential addition of monomers and the corresponding equilibrium self-
association constant, KX, is identical for each binding step [15,16]. 
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For the DNA-independent mechanism the two binding steps, namely self-assembly into the n-
mer state followed by binding of the n-mer to DNA, are statistically independent events and can 
be described as 
  
1 1
1 1 1
1
n
x x n N XC C K K N

    (1) 
where KN is the equilibrium binding constant of the n-mer with DNA; x1 and N1 are the numbers 
(or concentrations) of free (monomeric) ligand molecules and DNA binding sites, respectively 
and  11 11
!
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x
x
C
x
   is the number of ways to select one molecule out of x1 monomers. Taking 
into account that x1 >> n, the product of the 
1
1
xC  factors in Eq. 1 can be further simplified as 
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x x nC C x  |  , the common law of mass action typical of the independent binding events is 
yielded thus: 
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For the DNA-dependent mechanism, no distinct binding steps exist, because the binding with 
DNA and the formation of the n-mer occur simultaneously. Hence, the self-association and the 
DNA binding are statistically dependent events and the use of the law of mass action in the 
standard form of Eqs.1 and 2 is not valid. Recalling that the DNA-dependent and the DNA-
independent processes are enthalpically equivalent (i.e. the magnitude of the product X NK K  is 
similar for these two routes) the following binding term may be written 
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   describes the overall number of ways to make up an n-mer from x1 
monomers. 
 
Further simplification of Eq. 3 employing the condition x1 u n results in 
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The principal difference between Eq. 4 (DNA-dependent mechanism) and Eq. 2 (DNA-
independent mechanism) is the quantity 1 !n  originating from different probabilities of 
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independent formation of the n-mer in free solution as compared with the formation of the n-mer 
on the DNA template. This 1 !n  quantity lowers the magnitude of the DNA binding constant and 
gives unfavorable entropic contribution to the net Gibbs free energy change in the DNA-
dependent route of binding, equivalent to 
 
 ln !nS R n'    (5) 
 
As a consequence, it results in overall thermodynamic preference of the two-step binding process 
involving the n-mer pre-assembly stage. Note that this result is general. It does not introduce any 
assumptions regarding the nature of the ligands, their number in the binding domain and the type 
of the binding site. It is also only limited by the three empirical conditions (i)-(iii) listed above, 
which are typically valid for homo-dimeric binding of MGB ligands. If the same set of 
conditions also operates for other types of ligands assembling on the DNA template, so the 
conclusions drawn regarding the preferred route of binding may also be transferred to that type 
of ligand as well. 
 
For the DNA-dependent homo-dimeric binding (n=2) of MGB ligands, the entropic contribution 
in Eq. 5 is the smallest: lowering of the KN value occurs just by the factor 2 as compared with the 
DNA-independent route. Hence, the probabilistic nature of the preference for a DNA-
independent mechanism of homo-dimeric binding does not completely rule out the contribution 
from the DNA-dependent mechanism, i.e. in reality the mixture of both routes may operate on 
MGB binding with DNA. Nevertheless, the results of the present work for the first time reveal an 
entropic preference for the two-step process of DNA binding involving pre-assembly 
(dimerization) of MGB ligands in free solution. 
 
One may wonder on whether the factor of 2 (RTln§N-PRO may be important in terms of 
the net Gibbs free energy change on DNA ELQGLQJǻGbind? 7KHYDOXHRIǻGbind for monomeric 
DNA binding averaged over the set of typical MGB ligands is relatively high and equals to -
(9.1±1.4) kJ/mol (calculated from the data given in [17]). However, the resultant standard 
deviation, 1.4 kJ/mol, is relatively small and commensurate with the 1.7 kJ/mol equivalent of the 
factor of 2 in binding affinity. Hence, relatively small differences in binding affinities may be 
more important in terms of comparative analysis of MGB ligand binding with DNA than the 
absolute value of ǻGbind. 
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Methodological consequences of the entropic preference of a DNA-independent binding 
mechanism. 
 
Two principal methodological outcomes could be formulated regarding the revealed preference 
for a two-step homo-dimeric binding process. 
 
Firstly, as already stated in the introductory section, the approach for investigating homo-dimeric 
binding should not be limited to structural and/or thermodynamic exploration of the 2:1 binding 
process alone. The dimerization stage must be explored in detail in the absence of DNA in terms 
of structure and thermodynamics, which may throw light on the specificity of the formation of 
the given 2:1 complex in comparative analysis with other MGB ligands. 
 
Secondly, the binding model should contain in explicit form the dimerization of ligand with the 
self-association constant KX. If this is not introduced (as is the case in the majority of reported 
studies of homo-dimeric ligand binding to DNA), the magnitude of the experimentally measured 
apparent DNA binding constant, NK c  ( N N XK K Kc   ), will be strongly overestimated by the 
value of KX (which may take (1..10)·10
3 M-1 [7,9]), which may lead to erroneous conclusions 
when comparing binding affinities of various MGB ligands to DNA. 
 
In conclusion it may be stated that the route towards cooperative homo- or n-mer drug binding 
with DNA appears to be an important issue which must be addressed prior to any quantitative 
thermodynamic analysis of such processes. As a consequence of this work, the self-association 
properties of MGB ligands must be investigated in detail as a means of further deepening 
understanding of the highly cooperative homo-dimeric binding of clinically-important drugs with 
DNA. It also creates a challenge in searching for ways to experimentally distinguish between 
different routes of MGB binding with DNA. 
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